176 related articles for article (PubMed ID: 23349881)
21. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.
Skvara H; Kalthoff F; Meingassner JG; Wolff-Winiski B; Aschauer H; Kelleher JF; Wu X; Pan S; Mickel L; Schuster C; Stary G; Jalili A; David OJ; Emotte C; Antunes AM; Rose K; Decker J; Carlson I; Gardner H; Stuetz A; Bertolino AP; Stingl G; De Rie MA
J Invest Dermatol; 2011 Aug; 131(8):1735-44. PubMed ID: 21430703
[TBL] [Abstract][Full Text] [Related]
22. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia.
Moraes RC; Zhang X; Harrington N; Fung JY; Wu MF; Hilsenbeck SG; Allred DC; Lewis MT
Development; 2007 Mar; 134(6):1231-42. PubMed ID: 17287253
[TBL] [Abstract][Full Text] [Related]
23. Expressions of sonic hedgehog, patched, smoothened and Gli-1 in human intestinal stromal tumors and their correlation with prognosis.
Yoshizaki A; Nakayama T; Naito S; Wen CY; Sekine I
World J Gastroenterol; 2006 Sep; 12(35):5687-91. PubMed ID: 17007023
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas.
Gialmanidis IP; Bravou V; Amanetopoulou SG; Varakis J; Kourea H; Papadaki H
Lung Cancer; 2009 Oct; 66(1):64-74. PubMed ID: 19200615
[TBL] [Abstract][Full Text] [Related]
25. [The role of sonic hedgehog pathway in skin carcinogenesis].
Lesiak A; Sysa-Jedrzejowska A; Narbutt J
Pol Merkur Lekarski; 2010 Aug; 29(170):141-3. PubMed ID: 20842831
[TBL] [Abstract][Full Text] [Related]
26. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
[TBL] [Abstract][Full Text] [Related]
27. Hedgehog signalling in cancer.
Toftgård R
Cell Mol Life Sci; 2000 Nov; 57(12):1720-31. PubMed ID: 11130178
[TBL] [Abstract][Full Text] [Related]
28. Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion.
Bijlsma MF; Spek CA; Zivkovic D; van de Water S; Rezaee F; Peppelenbosch MP
PLoS Biol; 2006 Jul; 4(8):e232. PubMed ID: 16895439
[TBL] [Abstract][Full Text] [Related]
29. Smoothened gene alterations in keratocystic odontogenic tumors.
Rui Z; Li-Ying P; Jia-Fei Q; Ying-Ying H; Feng C; Tie-Jun L
Head Face Med; 2014 Sep; 10():36. PubMed ID: 25189937
[TBL] [Abstract][Full Text] [Related]
30. PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas.
Santos DC; Zaphiropoulos PG; Neto CF; Pimentel ER; Sanches JA; Ruiz IR
Int J Dermatol; 2011 Jul; 50(7):838-43. PubMed ID: 21699520
[TBL] [Abstract][Full Text] [Related]
31. Antisense Smo under the control of the PTCH1 promoter delivered by an adenoviral vector inhibits the growth of human pancreatic cancer.
Gao J; Li Z; Chen Z; Shao J; Zhang L; Xu G; Tu Z; Gong Y
Gene Ther; 2006 Nov; 13(22):1587-94. PubMed ID: 16826192
[TBL] [Abstract][Full Text] [Related]
32. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma.
Lupi O
Int J Dermatol; 2007 Nov; 46(11):1113-7. PubMed ID: 17988327
[TBL] [Abstract][Full Text] [Related]
33. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
[TBL] [Abstract][Full Text] [Related]
34. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas.
Ma X; Chen K; Huang S; Zhang X; Adegboyega PA; Evers BM; Zhang H; Xie J
Carcinogenesis; 2005 Oct; 26(10):1698-705. PubMed ID: 15905200
[TBL] [Abstract][Full Text] [Related]
35. Aberrant methylation of the PTCH1 gene promoter region in aberrant crypt foci.
Peng L; Hu J; Li S; Wang Z; Xia B; Jiang B; Li B; Zhang Y; Wang J; Wang X
Int J Cancer; 2013 Jan; 132(2):E18-25. PubMed ID: 22945423
[TBL] [Abstract][Full Text] [Related]
36. Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development.
Zhulyn O; Nieuwenhuis E; Liu YC; Angers S; Hui CC
Dev Biol; 2015 Jan; 397(2):191-202. PubMed ID: 25448692
[TBL] [Abstract][Full Text] [Related]
37. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.
Sharpe HJ; Pau G; Dijkgraaf GJ; Basset-Seguin N; Modrusan Z; Januario T; Tsui V; Durham AB; Dlugosz AA; Haverty PM; Bourgon R; Tang JY; Sarin KY; Dirix L; Fisher DC; Rudin CM; Sofen H; Migden MR; Yauch RL; de Sauvage FJ
Cancer Cell; 2015 Mar; 27(3):327-41. PubMed ID: 25759019
[TBL] [Abstract][Full Text] [Related]
38. Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors.
Wendling DS; Lück C; von Schweinitz D; Kappler R
Int J Mol Med; 2008 Dec; 22(6):787-92. PubMed ID: 19020777
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional profiles of SHH pathway genes in keratocystic odontogenic tumor and ameloblastoma.
Gurgel CA; Buim ME; Carvalho KC; Sales CB; Reis MG; de Souza RO; de Faro Valverde L; de Azevedo RA; Dos Santos JN; Soares FA; Ramos EA
J Oral Pathol Med; 2014 Sep; 43(8):619-26. PubMed ID: 24930892
[TBL] [Abstract][Full Text] [Related]
40. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts.
Ohki K; Kumamoto H; Ichinohasama R; Sato T; Takahashi N; Ooya K
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):584-92. PubMed ID: 15308259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
